Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24239TG2002PTC038926 Incorporated 09 May 2002 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹22.63 Cr
▼ 5.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.56 Cr
Issued & subscribed
Open charges
₹18.87 Cr
Satisfied ₹1.95 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
75
Latest available

About Disto Pharmaceuticals Private Limited

Data last updated: 18 December 2025

Disto Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 09 May 2002, the company has been in operation for over 24 years.

Registered with ROC Hyderabad under CIN U24239TG2002PTC038926.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.56 Cr. It is led by directors including Asith Kumar Mukherjee and Harish Chandra Pandey.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Plot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051.

As per the financials filed for FY 2024, the company reported a revenue of ₹22.63 Cr, a decline of 5% compared to the previous year.

The company has a workforce of approximately 75 employees as per the latest available data.

The company is associated with 1 brand - Disto Pharmaceuticals. As per MCA filings, the company has open charges of ₹18.87 Cr and satisfied charges of ₹1.95 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website distopharma.com.

Company Details of Disto Pharmaceuticals Private Limited
CIN U24239TG2002PTC038926
Registration Number 038926
Incorporation Date 09 May 2002
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Plot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051
  • Industry
    Pharma, Drug Formulation & Development
Company report
Disto Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Disto Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Disto Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24239AP2002PTC038926. The current CIN is U24239TG2002PTC038926, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24239TG2002PTC038926 Current
U24239AP2002PTC038926 Previous

Associated Brands with Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited operates one associated brand: Disto Pharmaceuticals. These brands represent Disto Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Develops and manufactures pharmaceutical pellets, granules, tablets, and capsules. distopharma.com

Competitors & Alternatives of Disto Pharmaceuticals Private Limited

Brands and companies operating in the same space as Disto Pharmaceuticals Private Limited include Encube Ethicals, Famar, Crown Laboratories and 5 more.

Competitor Description Location Founded
Encube Ethicals Encube Ethicals Contract development and manufacturing for topical semisolid formulations are provided. Mumbai, India, India 1998
Famar Famar Contract manufacturing and development services provider Athens, Greece, Greece 1949
Crown Laboratories Crown Laboratories OTC, prescription, skin care, and oral care products are manufactured. Johnson City, United States, United States 2000
Formulated Solutions Formulated Solutions Company offering CDMO services for the pharma (Rx and OTC), medical device, personal care and veterinary medicine sectors Largo, United States, United States 1999
Curida Curida Liquid pharmaceuticals are developed via blow fill seal technology. Elverum, Norway, Norway 2015
Chemineau Labs Chemineau Labs CDMO specializing in ENT and topical dosage forms Vouvray, France, France 1947
Contract Pharmaceuticals Contract Pharmaceuticals CDMO focused on manufacturing of semi-solid pharmaceutical drugs Mississauga, Canada, Canada 1991
Pharmasol Pharmasol Pharmasol is recognized as a Contract Development and Manufacturing Organization. Easton, United States, United States 1996

Business Activity of Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Disto Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited is audited by DHANUNJAYA & HARANATH for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
DHANUNJAYA & HARANATH Locked Locked Locked
Premium access

Complete auditor history for Disto Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited is currently managed by 4 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Asith Kumar Mukherjee Managing Director 15 Sep 2009 16 Years 11 Months Current
Harish Chandra Pandey Director 15 Sep 2009 16 Years 11 Months Current
Bidesh Mukherjee Whole-Time Director 15 Oct 2022 3 Years 10 Months Current
Krishna Raj Pandey Whole-Time Director 15 Oct 2022 3 Years 10 Months Current

Financials of Disto Pharmaceuticals Private Limited FY 2024 filings available

Disto Pharmaceuticals Private Limited reported revenue of ₹22.63 Cr (down 5.00% YoY) for FY 2024.

Revenue · FY 2024
₹22.63 Cr ▼ 5.00%
Premium access

Ten-year financial statements for Disto Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Disto Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Disto Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Disto Pharmaceuticals Private Limited

Open charges
₹18.87 Cr
Satisfied charges
₹1.95 Cr
Breakdown by lending institutions
Uco Bank₹18.06 Cr
Hdfc Bank Limited₹0.81 Cr
Latest charge details
DateLenderAmountStatus
09 Oct 2025 Uco Bank ₹9.61 Cr Open
03 Dec 2024 Uco Bank ₹84 Lakh Open
18 Sep 2024 Uco Bank ₹11.8 Lakh Open
05 Jul 2024 Hdfc Bank Limited ₹17.5 Lakh Open
28 May 2024 Hdfc Bank Limited ₹22.05 Lakh Open

Total charge records: 11 View all charges

Employees and EPFO Compliance at Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited has a workforce of 75 employees as of Mar 29, 2024.

Employee count
75
Active EPFO establishments
1
Employee growth
20.97%
Premium access

Employee and EPFO history for Disto Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Disto Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Disto Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Disto Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Disto Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Disto Pharmaceuticals Private Limited

Premium access

MSME payment history for Disto Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Disto Pharmaceuticals Private Limited

Premium access

Corporate group structure for Disto Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Disto Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Disto Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Disto Pharmaceuticals Private Limited

Charges
09 Oct 2025
A charge with Uco Bank amounted to Rs. 9.61 Cr with Charge ID 101171460 was registered on 09 Oct 2025.
Charges
03 Dec 2024
A charge with Uco Bank amounted to Rs. 0.84 Cr with Charge ID 101054918 was registered on 03 Dec 2024.
Activity
30 Sep 2024
Disto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
18 Sep 2024
A charge with Uco Bank amounted to Rs. 0.12 Cr with Charge ID 100982787 was registered on 18 Sep 2024.
Charges
05 Jul 2024
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100970273 was registered on 05 Jul 2024.
Charges
28 May 2024
A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 100949760 was registered on 28 May 2024.

Frequently Asked Questions about Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 09 May 2002 (24+ years old) and is registered under CIN U24239TG2002PTC038926. The company has 75 employees.

Disto Pharmaceuticals Private Limited reported revenue of ₹22.63 Cr for FY 2024 (down 5.00% YoY).

The current directors of Disto Pharmaceuticals Private Limited are:

The primary industry of Disto Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Disto Pharmaceuticals Private Limited can be reached at the registered office: Plot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051, or through the website distopharma.com.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹4.56 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available